Septal ablation in the treatment of hypertrophic myocardiopathy

Hypertrophic cardiomyopathy is a relative frequent disease and probably the most common genetic transmitted cardiovascular disease. Fortunately, the more aggressive varieties of the disease represent the less common manifestation of it. Outflow left ventricular obstruction is present in about 25 to...

Full description

Saved in:
Bibliographic Details
Published in:Archivos de cardiología de México 2002-01, Vol.72 Suppl 1, p.S18-S21
Main Author: Ban Hayashi, Ernesto
Format: Article
Language:Spanish
Subjects:
Cardiomyopathy, Hypertrophic - surgery
Catheter Ablation - adverse effects
Catheter Ablation - methods
Humans
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S21
container_issue
container_start_page S18
container_title Archivos de cardiología de México
container_volume 72 Suppl 1
creator Ban Hayashi, Ernesto
description Hypertrophic cardiomyopathy is a relative frequent disease and probably the most common genetic transmitted cardiovascular disease. Fortunately, the more aggressive varieties of the disease represent the less common manifestation of it. Outflow left ventricular obstruction is present in about 25 to 30% of the cases. Recently, septal ablation by means of the selective alcohol injection in left anterior descendent septal branches was introduced as a therapeutic alternative in cases associated with left ventricular outflow obstruction. Results with this technique have been encouraging with a success rate over 90%, and a low rate incidence of complications and mortality. These results are similar to those of surgical myectomy. We review indications, technique, and results obtained with this procedure.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71670067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71670067</sourcerecordid><originalsourceid>FETCH-LOGICAL-p542-39de2150bcb0c9cf7eed45468ea01e7461bdb70bc2354624dc32f369776a76e43</originalsourceid><addsrcrecordid>eNo1j0tLxDAYRbNQnHH0L0hW7gp5Z7ISGXzBgAtnX_L4SittE5N00X_vgOPqwrmHC_cKbakgsjFGkA26LeWbECYNkzdoQxkhdC_YFj19Qap2xNaNtg5xxsOMaw-4ZrB1grni2OF-TZBrjqkfPJ7W6G0OQ0y29usduu7sWOD-kjt0en05Hd6b4-fbx-H52CQpWMNNAEYlcd4Rb3ynAYKQQu3BEgpaKOqC0-ea8TNlInjOOq6M1spqBYLv0OPfbMrxZ4FS22koHsbRzhCX0mqqNCFKn8WHi7i4CUKb8jDZvLb_j_kvUG9RSw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71670067</pqid></control><display><type>article</type><title>Septal ablation in the treatment of hypertrophic myocardiopathy</title><source>EZB Electronic Journals Library</source><creator>Ban Hayashi, Ernesto</creator><creatorcontrib>Ban Hayashi, Ernesto</creatorcontrib><description>Hypertrophic cardiomyopathy is a relative frequent disease and probably the most common genetic transmitted cardiovascular disease. Fortunately, the more aggressive varieties of the disease represent the less common manifestation of it. Outflow left ventricular obstruction is present in about 25 to 30% of the cases. Recently, septal ablation by means of the selective alcohol injection in left anterior descendent septal branches was introduced as a therapeutic alternative in cases associated with left ventricular outflow obstruction. Results with this technique have been encouraging with a success rate over 90%, and a low rate incidence of complications and mortality. These results are similar to those of surgical myectomy. We review indications, technique, and results obtained with this procedure.</description><identifier>ISSN: 1405-9940</identifier><identifier>PMID: 12001842</identifier><language>spa</language><publisher>Mexico</publisher><subject>Cardiomyopathy, Hypertrophic - surgery ; Catheter Ablation - adverse effects ; Catheter Ablation - methods ; Humans</subject><ispartof>Archivos de cardiología de México, 2002-01, Vol.72 Suppl 1, p.S18-S21</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12001842$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ban Hayashi, Ernesto</creatorcontrib><title>Septal ablation in the treatment of hypertrophic myocardiopathy</title><title>Archivos de cardiología de México</title><addtitle>Arch Cardiol Mex</addtitle><description>Hypertrophic cardiomyopathy is a relative frequent disease and probably the most common genetic transmitted cardiovascular disease. Fortunately, the more aggressive varieties of the disease represent the less common manifestation of it. Outflow left ventricular obstruction is present in about 25 to 30% of the cases. Recently, septal ablation by means of the selective alcohol injection in left anterior descendent septal branches was introduced as a therapeutic alternative in cases associated with left ventricular outflow obstruction. Results with this technique have been encouraging with a success rate over 90%, and a low rate incidence of complications and mortality. These results are similar to those of surgical myectomy. We review indications, technique, and results obtained with this procedure.</description><subject>Cardiomyopathy, Hypertrophic - surgery</subject><subject>Catheter Ablation - adverse effects</subject><subject>Catheter Ablation - methods</subject><subject>Humans</subject><issn>1405-9940</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNo1j0tLxDAYRbNQnHH0L0hW7gp5Z7ISGXzBgAtnX_L4SittE5N00X_vgOPqwrmHC_cKbakgsjFGkA26LeWbECYNkzdoQxkhdC_YFj19Qap2xNaNtg5xxsOMaw-4ZrB1grni2OF-TZBrjqkfPJ7W6G0OQ0y29usduu7sWOD-kjt0en05Hd6b4-fbx-H52CQpWMNNAEYlcd4Rb3ynAYKQQu3BEgpaKOqC0-ea8TNlInjOOq6M1spqBYLv0OPfbMrxZ4FS22koHsbRzhCX0mqqNCFKn8WHi7i4CUKb8jDZvLb_j_kvUG9RSw</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>Ban Hayashi, Ernesto</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200201</creationdate><title>Septal ablation in the treatment of hypertrophic myocardiopathy</title><author>Ban Hayashi, Ernesto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p542-39de2150bcb0c9cf7eed45468ea01e7461bdb70bc2354624dc32f369776a76e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2002</creationdate><topic>Cardiomyopathy, Hypertrophic - surgery</topic><topic>Catheter Ablation - adverse effects</topic><topic>Catheter Ablation - methods</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ban Hayashi, Ernesto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archivos de cardiología de México</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ban Hayashi, Ernesto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Septal ablation in the treatment of hypertrophic myocardiopathy</atitle><jtitle>Archivos de cardiología de México</jtitle><addtitle>Arch Cardiol Mex</addtitle><date>2002-01</date><risdate>2002</risdate><volume>72 Suppl 1</volume><spage>S18</spage><epage>S21</epage><pages>S18-S21</pages><issn>1405-9940</issn><abstract>Hypertrophic cardiomyopathy is a relative frequent disease and probably the most common genetic transmitted cardiovascular disease. Fortunately, the more aggressive varieties of the disease represent the less common manifestation of it. Outflow left ventricular obstruction is present in about 25 to 30% of the cases. Recently, septal ablation by means of the selective alcohol injection in left anterior descendent septal branches was introduced as a therapeutic alternative in cases associated with left ventricular outflow obstruction. Results with this technique have been encouraging with a success rate over 90%, and a low rate incidence of complications and mortality. These results are similar to those of surgical myectomy. We review indications, technique, and results obtained with this procedure.</abstract><cop>Mexico</cop><pmid>12001842</pmid></addata></record>
fulltext fulltext
identifier ISSN: 1405-9940
ispartof Archivos de cardiología de México, 2002-01, Vol.72 Suppl 1, p.S18-S21
issn 1405-9940
language spa
recordid cdi_proquest_miscellaneous_71670067
source EZB Electronic Journals Library
subjects Cardiomyopathy, Hypertrophic - surgery
Catheter Ablation - adverse effects
Catheter Ablation - methods
Humans
title Septal ablation in the treatment of hypertrophic myocardiopathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T04%3A20%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Septal%20ablation%20in%20the%20treatment%20of%20hypertrophic%20myocardiopathy&rft.jtitle=Archivos%20de%20cardiolog%C3%ADa%20de%20M%C3%A9xico&rft.au=Ban%20Hayashi,%20Ernesto&rft.date=2002-01&rft.volume=72%20Suppl%201&rft.spage=S18&rft.epage=S21&rft.pages=S18-S21&rft.issn=1405-9940&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71670067%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p542-39de2150bcb0c9cf7eed45468ea01e7461bdb70bc2354624dc32f369776a76e43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71670067&rft_id=info:pmid/12001842&rfr_iscdi=true